Fully Engaged C-Suite Team

Purdue’s commitment to partnering is clearly evident with a fully engaged C‑suite team led by Dr. Craig Landau, President & Chief Executive Officer The entire Leadership Team is transforming Purdue from a leader in pain medicine to a partner of choice for collaborating in the development and commercialization of innovative ideas to improve healthcare for patients who suffer from a range of disease states.

Craig Landau HS SM Color

Craig Landau, MD

President & Chief Executive Officer

  • Joined Purdue in 1999
  • Previously Chief Medical Officer and Vice President of R&D Innovation, Clinical and Medical Affairs at Purdue Pharma
  • Physician with specialty training in chronic pain management
Alan Butcher

J. Alan Butcher

Senior Vice President, Business Development and Strategic Portfolio Management

  • Joined Purdue in April 2015
  • Previously VP of Business Development at Shire Pharmaceuticals
  • Past experience at Endo Pharmaceuticals, GlaxoSmithKline, Bristol-Myers Squibb
Stuart D. Baker

Stuart D. Baker

Counsel to the Board of Directors

  • Joined Purdue in 1994
Philip C. Strassburger

Philip C. Strassburger

Senior Vice President, Intellectual Property & Litigation

  • Joined Purdue in 1999
  • Previously with Pfizer
David Lundie

David Lundie

Head of Technical Operations (US) and Technical Operations Director (Rest of World)

  • Joined Purdue in 2004
  • Previously with Élan Pharmaceuticals

Margaret Feltz

Chief Ethics & Compliance Officer

  • Joined Purdue in 2004
  • Previously with Boehringer Ingelheim Pharmaceuticals, Inc.
Edward B. Mahony

Edward B. Mahony

Head of Due Diligence & Integration Management

  • Joined Purdue in 1993
  • Previously with Bristol-Myers Squibb
Alan Dunton

Alan W. Dunton, MD

Head of Research, Development & Regulatory Affairs

  • Joined Purdue in 2015
  • Previously with Danerius LLC, Panacos Pharmaceuticals, Metaphore Pharmaceuticals, Janssen Research Foundation (Johnson & Johnson)

Maria A. Barton

General Counsel

  • Joined Purdue in 2016
  • Previously with Latham & Watkins, New York

Josie Martin

Senior Vice President, Head of Corporate Affairs & Communications

  • Joined Purdue in 2017
  • Previously with PhRMA, Federation of American Hospitals, American Red Cross
Paul M HS Sm Color

Paul Medeiros

Senior Vice President, Corporate & Business Development

  • Joined Purdue in 2017
  • Previously with Mundipharma, Merck and Company, Schering-Plough, AVI BioPharma
Marv Kelly HS color

Marv Kelly

Head of Sales & Marketing

  • Joined Purdue in 2016
  • Previously with Endo Pharmaceuticals, GlaxoSmithKline, Centocor Ortho Biotech (Johnson & Johnson), Bayer
Karen Laurel HS lg Color

Karen Laurel

Head of Human Resources

  • Served as a human resources leader at Purdue for 17 years; returned to in 2017
  • Previously with Sikorsky Aircraft, Bayer Corporation and Middlesex Hospital

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.